Skip to main content

Advertisement

SpringerLink
Log in

How early? ASAP: molecular and functional imaging!

  • Focus on ...
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. http://www.m-w.com/dictionary/early

  2. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease. J Nucl Med 2006;47 11:1778–86.

    PubMed  CAS  Google Scholar 

  3. Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, et al. Enhanced brain activity may precede the diagnosis of Alzheimer’s disease by 30 years. Brain 2006;129 Pt 11:2908–22.

    Article  PubMed  Google Scholar 

  4. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006;355 25:2652–63.

    Article  PubMed  CAS  Google Scholar 

  5. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006;354 5:496–507.

    Article  PubMed  CAS  Google Scholar 

  6. Su H, Bodenstein C, Dumont RA, Seimbille Y, Dubinett S, Phelps ME, et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 2006;12 19:5659–67.

    Article  PubMed  CAS  Google Scholar 

  7. Linden HM, Krohn KA, Livingston RB, Mankoff DA. Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response? Clin Cancer Res 2006;12 19:5608–10.

    Article  PubMed  Google Scholar 

  8. Chaise C, Itti E, Petegnief Y, Wirquin E, Copie-Bergman C, Farcet JP, et al. [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model. Cancer Immunol Immunother DOI 10.1007/s00262-006-0265-02006 (Epub ahead of print).

  9. Kostakoglu L, Goldsmith SJ, Leonard JP, Christos P, Furman RR, Atasever T, et al. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease. Cancer 2006;107 11:2678–87.

    Article  PubMed  Google Scholar 

  10. Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 2006;24 34:5366–72.

    Article  PubMed  Google Scholar 

  11. Szyszko T, Al-Nahhas A, Canelo R, Habib N, Jiao L, Wasan H, et al. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: Value of FDG PET versus computed tomography. Nucl Med Commun 2007;28 1:15–20.

    Article  PubMed  Google Scholar 

  12. Mulder WJ, van der Schaft DW, Hautvast PA, Strijkers GJ, Koning GA, Storm G, et al. Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J Jan. 2007 (Epub ahead of print).

  13. Jingu K, Kaneta T, Nemoto K, Ichinose A, Oikawa M, Takai Y, et al. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys 2006;66 3:845–51.

    PubMed  Google Scholar 

  14. Mahmarian JJ, Shaw LJ, Filipchuk NG, Dakik HA, Iskander SS, Ruddy TD, et al. INSPIRE Investigators. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol 2006;48 12:2448–57.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo, Via Antonio di Rudinì, 8, 20142, Milan, Italy

    Giovanni Lucignani

Authors
  1. Giovanni Lucignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Lucignani.

Additional information

The commentaries in this section derive from a literature search and include summaries of articles compiled and linked to each other by using extensively the text contained in the articles examined.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucignani, G. How early? ASAP: molecular and functional imaging!. Eur J Nucl Med Mol Imaging 34, 596–601 (2007). https://doi.org/10.1007/s00259-007-0381-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0381-x

Keywords

Search

Navigation